Global Information
회사소개 | 문의 | 비교리스트

세계의 통증 한랭요법 시장 예측(-2027년) : 제품별(OTC 제품, 처방 제품), 적응증별(근골격계 장애, 수술후 치료, 스포츠 부상), 유통 채널별, 지역별

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application(Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel(Hospital, Retail, E-Pharmacy) - Global Forecast -2027

리서치사 MarketsandMarkets
발행일 2022년 06월 상품코드 1089147
페이지 정보 영문 240 Pages 배송안내
가격
US $ 4,950 ₩ 6,502,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,650 ₩ 8,735,000 PDF (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,150 ₩ 10,705,000 PDF (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없지만, 동일 국가의 동일 사업장에 한정되며 해외지점 등은 포함되지 않습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 10,000 ₩ 13,136,000 PDF (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 통증 한랭요법 시장 예측(-2027년) : 제품별(OTC 제품, 처방 제품), 적응증별(근골격계 장애, 수술후 치료, 스포츠 부상), 유통 채널별, 지역별 Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application(Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel(Hospital, Retail, E-Pharmacy) - Global Forecast -2027
발행일 : 2022년 06월 페이지 정보 : 영문 240 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 통증 한랭요법 시장 규모는 2022년 18억 달러에서 2027년까지 24억 달러에 이르고, 예측 기간에 연평균 복합 성장률(CAGR) 5.1%를 나타낼 것으로 예측됩니다.

시장 성장은 주로 관절염 이환율 증가와 적정 가격에 의한 제품 가용성에 기인한 것입니다.

세계의 통증 한랭요법(Cold Pain Therapy) 시장에 대해 조사분석했으며, 시장 개요, 업계 동향, 부문별 시장 분석, 경쟁 구도, 주요 기업 등에 대한 최신 정보를 제공합니다.

목차

제1장 서론

제2장 조사 방법

제3장 개요

제4장 프리미엄 인사이트

제5장 시장 개요

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 기회
    • 과제
    • 통증 한랭요법 시장에 대한 COVID-19의 영향
  • 가격 분석
  • 특허 분석
  • 밸류체인 분석
  • 공급망 분석
  • 에코시스템/시장 맵
  • Porter의 산업 분석
  • 규제 상황
  • 무역 분석
  • 기술 분석
  • 주요 컨퍼런스 및 이벤트
  • 고객의 비즈니스에 영향을 미치는 동향/혼란
  • 주요 이해관계자와 구입 기준
  • 사례 연구

제6장 통증 한랭요법 시장 : 제품별

  • OTC 제품
  • 처방 제품

제7장 통증 한랭요법 시장 : 적응증별

  • 근골격계 장애
  • 수술후 치료
  • 외상후 치료
  • 스포츠 부상

제8장 통증 한랭요법 시장 : 유통 채널별

  • 소매 약국
  • 병원 약국
  • E-PHARMACIES

제9장 통증 한랭요법 시장 : 지역별

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 기타 유럽
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 호주
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 기타 라틴아메리카
  • 중동 및 아프리카

제10장 경쟁 구도

  • 개요
  • 주요 기업의 전략/유력 기업
  • 주요 시장 기업의 매출 점유율 분석
  • 시장 점유율 분석
  • 기업 평가 매트릭스
  • 경쟁 리더십 매핑
  • 경쟁 벤치마킹
  • 경쟁 시나리오

제11장 기업 개요

  • 주요 기업
    • BEIERSDORF AG
    • DJO GLOBAL, INC.
    • HISAMITSU PHARMACEUTICAL CO., INC.
    • OSSUR
    • JOHNSON & JOHNSON
    • PFIZER
    • SANOFI
    • ROHTO PHARMACEUTICAL
    • 3M
    • CARDINAL HEALTH, INC.
  • 기타 기업
    • BREG, INC.
    • MEDLINE INDUSTRIES, INC.
    • PERFORMANCE HEALTH
    • ROMSONS GROUP OF INDUSTRIES
    • UNEXO LIFE SCIENCES PVT. LTD.
    • BIRD & CRONIN LLC
    • POLAR PRODUCTS INC.
    • RAPID AID CORP.
    • MUELLER SPORTS MEDICINE, INC.
    • PIC SOLUTION
    • BRUDER HEALTHCARE COMPANY
    • BROWNMED INC.
    • MEDICHILL
    • COMPASS HEALTH BRANDS
    • THERMOTEK, INC.

제12장 부록

LSH 22.06.21

The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost.

"The OTC products segment accounted for the highest growth rate in thecold pain therapymarket, by product, during the forecast period."

The cold pain therapy market is segmented into OTC products and prescription productsbased on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attributed to the easy accessibility of OTC products in retail and online pharmacies.

"E-pharmacies segment accounted for the highest CAGR."

Based on the distribution channel, the cold pain therapy market has been segmented into hospital pharmacies, retail pharmacies, and e-pharmacies. In 2021, the e-pharmaciessegment accounted for the highest growth rate. This can be attributed to the easy accessibility of medications coupled with added discounts.

"Asia Pacific: The fastest-growing regioncold pain therapymarket."

The global cold pain therapy market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period.Factors such as increasing geriatric population coupled with rising prevalence of arthritis and other musculoskeletal disorders.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%,and Tier 3 -30%
  • By Designation: C-level - 27%, D-level - 18%, and Others - 55%
  • By Region: North America -51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6%, and the Middle East & Africa - 4%

Lists of Companies Profiled in the Report:

  • Beiersdorf AG (Germany)
  • DJO Global, Inc. (US)
  • Hisamitsu Pharmaceutical Co., Inc. (Japan)
  • Ossur (Iceland)
  • Johnson & Johnson (US)
  • Pfizer (US)
  • Sanofi (France)
  • Rohto Pharmaceutical (Japan)
  • 3M (US)
  • Cardinal Health Inc. (US)
  • Bird & Cronin (US)
  • Compass Health Brands (US)
  • Breg, Inc. (US)
  • Medline Industries (US)
  • Performance Health (US)
  • Romsons Group of Industries (India
  • Unexo Life Sciences (India)
  • Polar Products (US)
  • Rapid Aid (Canada)
  • Mueller Sports Medicine (US)
  • Pic Solution (US)
  • Bruder Healthcare Company (US)
  • Brownmed Inc. (US)
  • Medichill (Australia)
  • ThermoTek, Inc. (US)

Research Coverage:

This report provides a detailed picture of the global cold pain therapymarket. It aims at estimating the size and future growth potential of the market across different segments, such as product,application, distribution channel,and region. The report also includes an in-depth competitive analysis ofthe key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall cold pain therapy market and its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS OF THE STUDY
  • 1.3 MARKETS COVERED
    • 1.3.1 COLD PAIN THERAPY MARKET
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH APPROACH
    • FIGURE 1 COLD PAIN THERAPY MARKET: RESEARCH DESIGN METHODOLOGY
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
      • 2.2.2.1 Primary sources
      • 2.2.2.2 Key data from primary sources
      • 2.2.2.3 Key industry insights
      • 2.2.2.4 Breakdown of primary interviews
    • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (COLD PAIN THERAPY MARKET)
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
      • 2.3.1.1 Approach 1: Company revenue estimation approach
    • FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
      • 2.3.1.2 Approach 2: Presentations of companies and primary interviews
      • 2.3.1.3 Growth forecast
      • 2.3.1.4 CAGR projections
    • FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • 2.3.2 TOP-DOWN APPROACH
    • FIGURE 6 COLD PAIN THERAPY MARKET: TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • 2.5 MARKET SHARE
  • 2.6 ASSUMPTIONS FOR THE STUDY
  • 2.7 LIMITATIONS
  • 2.8 RISK ASSESSMENT
    • 2.8.1 RISK ASSESSMENT: COLD PAIN THERAPY MARKET
  • 2.9 GROWTH RATE ASSUMPTIONS

3 EXECUTIVE SUMMARY

    • FIGURE 8 COLD PAIN THERAPY MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    • FIGURE 9 COLD PAIN THERAPY MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    • FIGURE 10 COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022 VS. 2027 (USD MILLION)
    • FIGURE 11 COLD PAIN THERAPY MARKET, BY REGION, 2022 VS. 2027 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 COLD PAIN THERAPY MARKET OVERVIEW
    • FIGURE 12 GROWING PREVALENCE OF MUSCULOSKELETAL CONDITIONS AND INCREASING PARTICIPATION IN SPORTS TO DRIVE MARKET GROWTH
  • 4.2 COLD PAIN THERAPY MARKET SHARE, BY PRODUCT, 2022 VS. 2027
    • FIGURE 13 OTC PRODUCTS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2027
  • 4.3 COLD PAIN THERAPY MARKET SHARE, BY APPLICATION, 2022 VS. 2027
    • FIGURE 14 MUSCULOSKELETAL DISORDERS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • 4.4 COLD PAIN THERAPY MARKET SHARE, BY DISTRIBUTION CHANNEL, 2022 VS. 2027
    • FIGURE 15 RETAIL PHARMACIES SEGMENT TO CONTINUE TO DOMINATE THE MARKET IN 2027
  • 4.5 COLD PAIN THERAPY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 16 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE COLD PAIN THERAPY MARKET DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 17 COLD PAIN THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing incidence of sports injuries and rising emphasis on exercise and gym activities
      • 5.2.1.2 Growing number of hip and knee surgeries across the globe
      • 5.2.1.3 Rising geriatric population and subsequent growth in the prevalence of bone diseases and trauma injuries
      • 5.2.1.4 Growing need for safer pain management modalities as opposed to oral drug therapy
      • 5.2.1.5 Clinical evidence in favor of menthol-based topical analgesics
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Wide use of low-priced analgesic pills for immediate pain relief
      • 5.2.2.2 Lack of substantial clinical evidence and reimbursement in favor of cold pain therapy
      • 5.2.2.3 Health hazards and discomfort associated with cold pain therapy products
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing adoption of analgesic patches
      • 5.2.3.2 Growing use of cold pain therapy among middle-aged women
      • 5.2.3.3 Increasing regulatory barriers for oral pain medications
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Availability of alternative non-drug/device pain management therapies
    • 5.2.5 IMPACT OF COVID-19 ON THE COLD PAIN THERAPY MARKET
  • 5.3 PRICING ANALYSIS
    • TABLE 1 AVERAGE SELLING PRICE OF COLD PAIN THERAPY PRODUCTS (2022)
  • 5.4 PATENT ANALYSIS
    • FIGURE 18 PATENT ANALYSIS FOR MOTORIZED COLD PAIN THERAPY DEVICES
    • TABLE 2 LIST OF KEY PATENTS
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 19 VALUE CHAIN ANALYSIS OF THE COLD PAIN THERAPY MARKET: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
  • 5.6 SUPPLY CHAIN ANALYSIS
    • FIGURE 20 COLD PAIN THERAPY MARKET: SUPPLY CHAIN ANALYSIS
  • 5.7 ECOSYSTEM/MARKET MAP
    • FIGURE 21 COLD PAIN THERAPY MARKET: ECOSYSTEM/MARKET MAP
    • TABLE 3 COLD PAIN THERAPY MARKET: ROLE IN ECOSYSTEM
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 4 COLD PAIN THERAPY MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.8.1 THREAT OF NEW ENTRANTS
    • 5.8.2 THREAT OF SUBSTITUTES
    • 5.8.3 BARGAINING POWER OF BUYERS
    • 5.8.4 BARGAINING POWER OF SUPPLIERS
    • 5.8.5 DEGREE OF COMPETITION
  • 5.9 REGULATORY LANDSCAPE
    • TABLE 5 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 6 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 7 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 9 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.9.1 NORTH AMERICA
      • 5.9.1.1 US
      • 5.9.1.2 Canada
    • 5.9.2 EUROPE
    • 5.9.3 ASIA PACIFIC
      • 5.9.3.1 Japan
      • 5.9.3.2 India
    • 5.9.4 LATIN AMERICA
      • 5.9.4.1 Brazil
      • 5.9.4.2 Mexico
    • 5.9.5 MIDDLE EAST
    • 5.9.6 AFRICA
  • 5.10 TRADE ANALYSIS
    • 5.10.1 TRADE ANALYSIS FOR COLD PAIN THERAPY PRODUCTS
    • TABLE 10 IMPORT DATA FOR ARTICLES AND EQUIPMENT FOR SPORTS AND OUTDOOR GAMES, BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 11 EXPORT DATA FOR ARTICLES AND EQUIPMENT FOR SPORTS AND OUTDOOR GAMES, BY COUNTRY, 2017-2021 (USD MILLION)
  • 5.11 TECHNOLOGY ANALYSIS
  • 5.12 KEY CONFERENCES & EVENTS IN 2022-2023
    • TABLE 12 COLD PAIN THERAPY MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • 5.13.1 REVENUE SOURCES ARE SHIFTING TOWARD SAFER PAIN MANAGEMENT DUE TO THE COVID-19 PANDEMIC
    • FIGURE 22 REVENUE SHIFT IN THE COLD PAIN THERAPY MARKET
  • 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.14.1 KEY STAKEHOLDERS IN THE BUYING PROCESS
    • FIGURE 23 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS OF COLD PAIN THERAPY PRODUCTS
    • TABLE 13 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS OF COLD PAIN THERAPY PRODUCTS
    • 5.14.2 BUYING CRITERIA
    • FIGURE 24 KEY BUYING CRITERIA FOR COLD PAIN THERAPY PRODUCTS
    • TABLE 14 KEY BUYING CRITERIA FOR COLD PAIN THERAPY PRODUCTS
  • 5.15 CASE STUDIES
    • 5.15.1 CASE STUDY 1

6 COLD PAIN THERAPY MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 15 COLD PAIN THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  • 6.2 OTC PRODUCTS
    • TABLE 16 COLD PAIN THERAPY OTC PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 17 COLD PAIN THERAPY OTC PRODUCTS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 18 COLD PAIN THERAPY OTC PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • TABLE 19 COLD PAIN THERAPY OTC PRODUCTS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.2.1 OTC PHARMACEUTICALS
    • TABLE 20 COLD PAIN THERAPY OTC PHARMACEUTICALS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 21 COLD PAIN THERAPY OTC PHARMACEUTICALS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 22 COLD PAIN THERAPY OTC PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • TABLE 23 COLD PAIN THERAPY OTC PHARMACEUTICALS MARKET, BY REGION, 2020-2027 (USD MILLION)
      • 6.2.1.1 Gels, ointments, and creams
        • 6.2.1.1.1 Gels, ointments, and creams offer effective orthopedic pain management
    • TABLE 24 KEY GELS, OINTMENTS, AND CREAMS AVAILABLE IN THE MARKET
    • TABLE 25 COLD PAIN THERAPY MARKET FOR GELS, OINTMENTS, AND CREAMS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 26 COLD PAIN THERAPY MARKET FOR GELS, OINTMENTS, AND CREAMS, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 27 COLD PAIN THERAPY MARKET FOR GELS, OINTMENTS, AND CREAMS, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
      • 6.2.1.2 Sprays and foams
        • 6.2.1.2.1 Procedural benefits offered by sprays and foams to increase their adoption among sportspersons
    • TABLE 28 KEY SPRAYS AND FOAMS AVAILABLE IN THE MARKET
    • TABLE 29 COLD PAIN THERAPY MARKET FOR SPRAYS AND FOAMS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 30 COLD PAIN THERAPY MARKET FOR SPRAYS AND FOAMS, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 31 COLD PAIN THERAPY MARKET FOR SPRAYS AND FOAMS, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
      • 6.2.1.3 Patches
        • 6.2.1.3.1 Ability to deliver consistent dosage of drugs over topical creams resulting in the greater consumption of cold pain patches
    • TABLE 32 KEY PATCHES AVAILABLE IN THE MARKET
    • TABLE 33 COLD PAIN THERAPY MARKET FOR PATCHES, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 34 COLD PAIN THERAPY MARKET FOR PATCHES, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 35 COLD PAIN THERAPY MARKET FOR PATCHES, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
      • 6.2.1.4 Roll-ons
        • 6.2.1.4.1 Inconsistent drug delivery and the need for repetitive use on skin are expected to hamper the adoption of roll-ons
    • TABLE 36 COLD PAIN THERAPY MARKET FOR ROLL-ONS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 37 COLD PAIN THERAPY MARKET FOR ROLL-ONS, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 38 COLD PAIN THERAPY MARKET FOR ROLL-ONS, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • 6.2.2 OTC MEDICAL DEVICES
    • TABLE 39 COLD PAIN THERAPY OTC MEDICAL DEVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 40 COLD PAIN THERAPY OTC MEDICAL DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 41 COLD PAIN THERAPY OTC MEDICAL DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • TABLE 42 COLD PAIN THERAPY OTC MEDICAL DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
      • 6.2.2.1 Cold packs
        • 6.2.2.1.1 Cold packs are among the widely used cold pain therapy medical devices
    • TABLE 43 KEY COLD PACKS AVAILABLE IN THE MARKET
    • TABLE 44 COLD PAIN THERAPY MARKET FOR COLD PACKS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 45 COLD PAIN THERAPY MARKET FOR COLD PACKS, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 46 COLD PAIN THERAPY MARKET FOR COLD PACKS, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
      • 6.2.2.2 Cooling towels, compresses, wraps, and pads
        • 6.2.2.2.1 Growing availability of wraps and cooling pads to aid the growth of this market segment
    • TABLE 47 KEY COOLING TOWELS, COMPRESSES, WRAPS, AND PADS AVAILABLE IN THE MARKET
    • TABLE 48 COLD PAIN THERAPY MARKET FOR COOLING TOWELS, COMPRESSES, WRAPS, AND PADS, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 49 COLD PAIN THERAPY MARKET FOR COOLING TOWELS, COMPRESSES, WRAPS, AND PADS, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 50 COLD PAIN THERAPY MARKET FOR COOLING TOWELS, COMPRESSES, WRAPS, AND PADS, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
  • 6.3 PRESCRIPTION PRODUCTS
    • TABLE 51 KEY PRESCRIPTION PRODUCTS AVAILABLE IN THE MARKET
    • TABLE 52 COLD PAIN THERAPY PRESCRIPTION PRODUCTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 53 COLD PAIN THERAPY PRESCRIPTION PRODUCTS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 54 COLD PAIN THERAPY PRESCRIPTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • TABLE 55 COLD PAIN THERAPY PRESCRIPTION PRODUCTS MARKET, BY REGION, 2020-2027 (USD MILLION)
    • 6.3.1 MOTORIZED DEVICES
      • 6.3.1.1 Preference for motorized devices is increasing among patients
    • TABLE 56 COLD PAIN THERAPY MARKET FOR MOTORIZED DEVICES, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 57 COLD PAIN THERAPY MARKET FOR MOTORIZED DEVICES, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 58 COLD PAIN THERAPY MARKET FOR MOTORIZED DEVICES, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • 6.3.2 NON-MOTORIZED DEVICES
      • 6.3.2.1 Non-motorized devices cost lower as compared to motorized devices
    • TABLE 59 COLD PAIN THERAPY MARKET FOR NON-MOTORIZED DEVICES, BY REGION, 2020-2027 (USD MILLION)
    • TABLE 60 COLD PAIN THERAPY MARKET FOR NON-MOTORIZED DEVICES, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 61 COLD PAIN THERAPY MARKET FOR NON-MOTORIZED DEVICES, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)

7 COLD PAIN THERAPY MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • TABLE 62 COLD PAIN THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
  • 7.2 MUSCULOSKELETAL DISORDERS
    • 7.2.1 INCREASING PREVALENCE OF MUSCULOSKELETAL DISORDERS TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
    • TABLE 63 COLD PAIN THERAPY MARKET FOR MUSCULOSKELETAL DISORDERS, BY REGION, 2020-2027 (USD MILLION)
  • 7.3 POST-OPERATIVE THERAPY
    • 7.3.1 INCREASING NUMBER OF ORTHOPEDIC SURGICAL PROCEDURES TO DRIVE SEGMENT GROWTH
    • TABLE 64 COLD PAIN THERAPY MARKET FOR POST-OPERATIVE THERAPY, BY REGION, 2020-2027 (USD MILLION)
  • 7.4 POST-TRAUMA THERAPY
    • 7.4.1 INCREASING INCIDENCE OF TRAUMA INJURIES TO PROPEL SEGMENT GROWTH
    • TABLE 65 COLD PAIN THERAPY MARKET FOR POST-TRAUMA THERAPY, BY REGION, 2020-2027 (USD MILLION)
  • 7.5 SPORTS INJURIES
    • 7.5.1 INCREASING NUMBER OF SPORTS INJURIES TO DRIVE SEGMENT GROWTH
    • TABLE 66 COLD PAIN THERAPY MARKET FOR SPORTS INJURIES, BY REGION, 2020-2027 (USD MILLION)

8 COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL

  • 8.1 INTRODUCTION
    • TABLE 67 COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
  • 8.2 RETAIL PHARMACIES
    • 8.2.1 RETAIL PHARMACIES FORM THE LARGEST DISTRIBUTION CHANNEL FOR COLD PAIN THERAPY PRODUCTS
    • TABLE 68 COLD PAIN THERAPY MARKET FOR RETAIL PHARMACIES, BY REGION, 2020-2027 (USD MILLION)
  • 8.3 HOSPITAL PHARMACIES
    • 8.3.1 IMPROVING HEALTHCARE INFRASTRUCTURE TO DRIVE SEGMENT GROWTH
    • TABLE 69 COLD PAIN THERAPY MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2020-2027 (USD MILLION)
  • 8.4 E-PHARMACIES
    • 8.4.1 E-PHARMACIES SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
    • TABLE 70 COLD PAIN THERAPY MARKET FOR E-PHARMACIES, BY REGION, 2020-2027 (USD MILLION)

9 COLD PAIN THERAPY MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 71 COLD PAIN THERAPY MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 25 NORTH AMERICA: COLD PAIN THERAPY MARKET SNAPSHOT
    • TABLE 72 NORTH AMERICA: COLD PAIN THERAPY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 73 NORTH AMERICA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 74 NORTH AMERICA: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 75 NORTH AMERICA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 Strong presence of key companies has driven market growth in the US
    • TABLE 76 US: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 77 US: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 78 US: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 79 US: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 80 US: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 81 US: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 82 US: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Market growth is driven by the rising number of hip and knee replacement surgeries
    • TABLE 83 CANADA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 84 CANADA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 85 CANADA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 86 CANADA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 87 CANADA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 88 CANADA: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 89 CANADA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 90 EUROPE: COLD PAIN THERAPY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 91 EUROPE: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 92 EUROPE: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 93 EUROPE: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Increasing healthcare expenditure to drive market growth in Germany
    • TABLE 94 GERMANY: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 95 GERMANY: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 96 GERMANY: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 97 GERMANY: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 98 GERMANY: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 99 GERMANY: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 100 GERMANY: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • 9.3.2 UK
      • 9.3.2.1 Market growth in the UK is mainly driven by the increasing prevalence of musculoskeletal conditions
    • TABLE 101 UK: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 102 UK: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 103 UK: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 104 UK: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 105 UK: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 106 UK: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 107 UK: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Increasing target patient population to drive market growth in France
    • TABLE 108 FRANCE: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 109 FRANCE: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 110 FRANCE: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 111 FRANCE: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 112 FRANCE: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 113 FRANCE: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 114 FRANCE: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 Growing public awareness about the preventive care of musculoskeletal disorders to drive market growth
    • TABLE 115 ITALY: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 116 ITALY: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 117 ITALY: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 118 ITALY: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 119 ITALY: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 120 ITALY: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 121 ITALY: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Increasing prevalence of target diseases to drive market growth
    • TABLE 122 SPAIN: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 123 SPAIN: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 124 SPAIN: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 125 SPAIN: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 126 SPAIN: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 127 SPAIN: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 128 SPAIN: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • 9.3.6 REST OF EUROPE
    • TABLE 129 NUMBER OF SURGERIES CONDUCTED IN ROE COUNTRIES
    • TABLE 130 ROE: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 131 ROE: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 132 ROE: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 133 ROE: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 134 ROE: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 135 ROE: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 136 ROE: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 26 APAC: COLD PAIN THERAPY MARKET SNAPSHOT
    • TABLE 137 ASIA PACIFIC: COLD PAIN THERAPY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 138 ASIA PACIFIC: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 139 ASIA PACIFIC: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 140 ASIA PACIFIC: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • 9.4.1 JAPAN
      • 9.4.1.1 Increasing geriatric population to drive market growth in Japan
    • TABLE 141 JAPAN: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 142 JAPAN: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 143 JAPAN: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 144 JAPAN: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 145 JAPAN: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 146 JAPAN: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 147 JAPAN: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • 9.4.2 CHINA
      • 9.4.2.1 Expansion in the target patient population to drive market growth
    • TABLE 148 CHINA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 149 CHINA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 150 CHINA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 151 CHINA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 152 CHINA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 153 CHINA: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 154 CHINA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 Growing number of arthritis cases to drive market growth
    • TABLE 155 INDIA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 156 INDIA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 157 INDIA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 158 INDIA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 159 INDIA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 160 INDIA: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 161 INDIA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • 9.4.4 AUSTRALIA
      • 9.4.4.1 Rising prevalence of target diseases to drive market growth
    • TABLE 162 AUSTRALIA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 163 AUSTRALIA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 164 AUSTRALIA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 165 AUSTRALIA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 166 AUSTRALIA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 167 AUSTRALIA: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 168 AUSTRALIA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • 9.4.5 SOUTH KOREA
      • 9.4.5.1 Supportive government initiatives are expected to positively impact market growth
    • TABLE 169 SOUTH KOREA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 170 SOUTH KOREA: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 171 SOUTH KOREA: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 172 SOUTH KOREA: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 173 SOUTH KOREA: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 174 SOUTH KOREA: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 175 SOUTH KOREA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • 9.4.6 REST OF ASIA PACIFIC
    • TABLE 176 ROAPAC: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 177 ROAPAC: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 178 ROAPAC: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 179 ROAPAC: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 180 ROAPAC: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 181 ROAPAC: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 182 ROAPAC: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
  • 9.5 LATIN AMERICA
    • TABLE 183 LATIN AMERICA: COLD PAIN THERAPY MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 184 LATIN AMERICA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 185 LATIN AMERICA: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 186 LATIN AMERICA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • 9.5.1 BRAZIL
      • 9.5.1.1 Growing obese population will drive market growth in Brazil
    • TABLE 187 BRAZIL: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 188 BRAZIL: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 189 BRAZIL: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 190 BRAZIL: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 191 BRAZIL: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 192 BRAZIL: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 193 BRAZIL: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • 9.5.2 MEXICO
      • 9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth
    • TABLE 194 MEXICO: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 195 MEXICO: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 196 MEXICO: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 197 MEXICO: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 198 MEXICO: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 199 MEXICO: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 200 MEXICO: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
    • 9.5.3 REST OF LATIN AMERICA
    • TABLE 201 ROLATAM: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 202 ROLATAM: COLD PAIN THERAPY MARKET FOR OTC PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 203 ROLATAM: COLD PAIN THERAPY MARKET FOR OTC PHARMACEUTICALS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 204 ROLATAM: COLD PAIN THERAPY MARKET FOR OTC MEDICAL DEVICES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 205 ROLATAM: COLD PAIN THERAPY MARKET FOR PRESCRIPTION PRODUCTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 206 ROLATAM: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 207 ROLATAM: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • TABLE 208 MIDDLE EAST & AFRICA: COLD PAIN THERAPY MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 209 MIDDLE EAST & AFRICA: COLD PAIN THERAPY MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 210 MIDDLE EAST & AFRICA: COLD PAIN THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE COLD PAIN THERAPY MARKET
    • TABLE 211 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COLD PAIN THERAPY PRODUCT MANUFACTURING COMPANIES
  • 10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • FIGURE 27 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN THE COLD PAIN THERAPY MARKET
  • 10.4 MARKET SHARE ANALYSIS
    • 10.4.1 COLD PAIN THERAPY MARKET
    • FIGURE 28 COLD PAIN THERAPY MARKET SHARE, BY KEY PLAYER (2021)
    • TABLE 212 COLD PAIN THERAPY MARKET: DEGREE OF COMPETITION
    • 10.4.2 EUROPE: COLD PAIN THERAPY MARKET SHARE OF PLAYERS
    • FIGURE 29 EUROPE: COLD PAIN THERAPY MARKET SHARE OF TOP 3 PLAYERS (2021)
    • 10.4.3 EUROPE: LIST OF KEY PLAYERS (2021)
  • 10.5 COMPANY EVALUATION MATRIX
    • 10.5.1 LIST OF EVALUATED VENDORS
    • 10.5.2 STARS
    • 10.5.3 EMERGING LEADERS
    • 10.5.4 PERVASIVE PLAYERS
    • 10.5.5 PARTICIPANTS
    • FIGURE 30 COLD PAIN THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
  • 10.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2021)
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 STARTING BLOCKS
    • 10.6.3 RESPONSIVE COMPANIES
    • 10.6.4 DYNAMIC COMPANIES
    • FIGURE 31 COLD PAIN THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2021
  • 10.7 COMPETITIVE BENCHMARKING
    • 10.7.1 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS
    • FIGURE 32 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN THE COLD PAIN THERAPY MARKET
    • TABLE 213 COLD PAIN THERAPY MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
    • TABLE 214 PRODUCT FOOTPRINT OF KEY PLAYERS
    • TABLE 215 REGIONAL FOOTPRINT OF KEY PLAYERS
    • TABLE 216 COLD PAIN THERAPY MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • 10.8 COMPETITIVE SCENARIO
    • 10.8.1 PRODUCT LAUNCHES
    • TABLE 217 KEY PRODUCT LAUNCHES & REGULATORY APPROVALS
    • 10.8.2 DEALS
    • TABLE 218 KEY DEALS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS

(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**

    • 11.1.1 BEIERSDORF AG
    • TABLE 219 BEIERSDORF AG: BUSINESS OVERVIEW
    • FIGURE 33 BEIERSDORF AG: COMPANY SNAPSHOT (2021)
    • 11.1.2 DJO GLOBAL, INC.
    • TABLE 220 DJO GLOBAL, INC.: BUSINESS OVERVIEW
    • FIGURE 34 DJO GLOBAL, INC.: COMPANY SNAPSHOT (2020)
    • 11.1.3 HISAMITSU PHARMACEUTICAL CO., INC.
    • TABLE 221 HISAMITSU PHARMACEUTICAL CO., INC.: BUSINESS OVERVIEW
    • FIGURE 35 HISAMITSU PHARMACEUTICAL CO., INC.: COMPANY SNAPSHOT (2021)
    • 11.1.4 OSSUR
    • TABLE 222 OSSUR: BUSINESS OVERVIEW
    • FIGURE 36 OSSUR: COMPANY SNAPSHOT (2021)
    • 11.1.5 JOHNSON & JOHNSON
    • TABLE 223 JOHNSON & JOHNSON: BUSINESS OVERVIEW
    • FIGURE 37 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2021)
    • 11.1.6 PFIZER
    • TABLE 224 PFIZER: BUSINESS OVERVIEW
    • FIGURE 38 PFIZER: COMPANY SNAPSHOT (2021)
    • 11.1.7 SANOFI
    • TABLE 225 SANOFI: BUSINESS OVERVIEW
    • FIGURE 39 SANOFI: COMPANY SNAPSHOT (2021)
    • 11.1.8 ROHTO PHARMACEUTICAL
    • TABLE 226 ROHTO PHARMACEUTICAL: BUSINESS OVERVIEW
    • FIGURE 40 ROHTO PHARMACEUTICAL: COMPANY SNAPSHOT (2021)
    • 11.1.9 3M
    • TABLE 227 3M: BUSINESS OVERVIEW
    • FIGURE 41 3M: COMPANY SNAPSHOT (2021)
    • 11.1.10 CARDINAL HEALTH, INC.
    • TABLE 228 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW
    • FIGURE 42 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2021)
  • *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
  • 11.2 OTHER PLAYERS
    • 11.2.1 BREG, INC.
    • TABLE 229 BREG, INC.: COMPANY OVERVIEW
    • 11.2.2 MEDLINE INDUSTRIES, INC.
    • TABLE 230 MEDLINE INDUSTRIES, INC.: COMPANY OVERVIEW
    • 11.2.3 PERFORMANCE HEALTH
    • TABLE 231 PERFORMANCE HEALTH: COMPANY OVERVIEW
    • 11.2.4 ROMSONS GROUP OF INDUSTRIES
    • TABLE 232 ROMSONS GROUP OF INDUSTRIES: COMPANY OVERVIEW
    • 11.2.5 UNEXO LIFE SCIENCES PVT. LTD.
    • TABLE 233 UNEXO LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW
    • 11.2.6 BIRD & CRONIN LLC
    • TABLE 234 BIRD & CRONIN LLC: COMPANY OVERVIEW
    • 11.2.7 POLAR PRODUCTS INC.
    • TABLE 235 POLAR PRODUCTS INC.: COMPANY OVERVIEW
    • 11.2.8 RAPID AID CORP.
    • TABLE 236 RAPID AID CORP.: COMPANY OVERVIEW
    • 11.2.9 MUELLER SPORTS MEDICINE, INC.
    • TABLE 237 MUELLER SPORTS MEDICINE, INC.: COMPANY OVERVIEW
    • 11.2.10 PIC SOLUTION
    • TABLE 238 PIC SOLUTION: COMPANY OVERVIEW
    • 11.2.11 BRUDER HEALTHCARE COMPANY
    • TABLE 239 BRUDER HEALTHCARE COMPANY: COMPANY OVERVIEW
    • 11.2.12 BROWNMED INC.
    • TABLE 240 BROWNMED INC.: COMPANY OVERVIEW
    • 11.2.13 MEDICHILL
    • TABLE 241 MEDICHILL: COMPANY OVERVIEW
    • 11.2.14 COMPASS HEALTH BRANDS
    • TABLE 242 COMPASS HEALTH BRANDS: COMPANY OVERVIEW
    • 11.2.15 THERMOTEK, INC.
    • TABLE 243 THERMOTEK, INC.: COMPANY OVERVIEW

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
Back to Top
전화 문의
F A Q